REBLOZYL® (luspatercept-aamt) logo
Now approved for earlier treatment of MDS-related anemia badge

INDICATIONS (1 of 3)

REBLOZYL® (luspatercept-aamt) is a prescription medicine for injection, and is used to treat anemia (low red blood cells) in adults with myelodysplastic syndromes who may need RBC transfusions and have never received another type of medicine called an erythropoiesis stimulating agent (ESA).

REBLOZYL is not a substitute for RBC transfusions in people who need immediate treatment for anemia.

It is not known if REBLOZYL is safe or effective in children under 18 years of age.

Hypothetical patient with anemia in myelodysplastic syndromes with ring sideroblasts (MDS-RS) Hypothetical patient with anemia in myelodysplastic syndromes with ring sideroblasts (MDS-RS)

NOW
APPROVED

for earlier treatment
of MDS-related anemia.

Come back soon
for more information.

NOW
APPROVED

for earlier treatment
of MDS-related anemia.

Come back soon
for more information.

Anemia in adults
with myelodysplastic
syndromes (MDS)

REBLOZYL for MDS